Bio-evaluation of alkaloids and saponins from bitter melon: Probing more desirable compound in treating hyperglycemia and hyperlipidemia

References

• Abas, R., Das, S., & Thent, Z. C. (2015). Momordica charantia fruit extract improve subcellular changes in cardiovascular tissues of diabetic rats. Journal of Medical & Bioengineering, 4(5), 357–16. https://doi.org/10.12720/jomb.4.5.357-362
   Google Scholar
• Abdollah, M., Zuki, A. B. Z., Goh, Y. M., Rezaeizadeh, A., & Noordin, M. M. (2010). The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. African Journal of Biotechnology, 9(31), 5004–5012.
   Google Scholar
• Abo-Ghanema, I., & Saleh, R. (2012). Some physiological effects of Momordica charantia and trigonella foenum-graecum extracts in diabetic rats as compared with Cidophage. International Journal of Animal and Veterinary Sciences, 6(4), 222–230. https://doi.org/10.5281/zenodo.1086261
   Google Scholar
• Ahn, J., Choi, W., Kim, S., & Ha, T. (2011). Anti-diabetic effect of watermelon (Citrullus vulgaris Schrad) on streptozotocin-induced diabetic mice. Food Science & Biotechnology, 20(1), 251–254. https://doi.org/10.1007/s10068-011-0034-5
   Web of Science ®Google Scholar
• Akhtar, N., Khan, B. A., Majid, A., Khan, S., Mahmood, T., Gulfishan, G., & Saeed, T. (2011). Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta poloniae pharmaceutica, 68(6), 919–925.
   PubMed Web of Science ®Google Scholar
• Al-Neaimy, K. S. A. (2008). Comparative effect of metformin and glibenclamide on lipid profile in type 2 diabetic patients. Tikrit Journal of Pharmaceutical Sciences, 1(1), 46–50. https://www.iasj.net/iasj/download/d4a9c649dbfac3c3
   Google Scholar
• Alshatwi, A. A., Al Obaaid, M. A., Al Sedairy, S. A., Al-Assaf, A. H., Zhang, J. J., & Lei, K. Y. (2010). Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutrition Research, 30(1), 66–73. https://doi.org/10.1016/j.nutres.2009.12.002
   PubMed Web of Science ®Google Scholar
• Arshad, F., Saeed, M. S., Nadeem, M. T., Arshad, M. U., Nadeem, M. T., & Arshad, M. U. (2017). Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia). Lipids in Health and Disease, 16(1), 1–11. https://doi.org/10.1186/s12944-017-0602-7
   PubMedGoogle Scholar
• Bano, F., Akthar, N., & Naz, H. (2011). Effect of the aqueous extract of Momordica charantia on body weight of rats. Journal of Basic & Applied Sciences, 7(1), 1–5.
   Google Scholar
• Bhushan, M. S., Rao, C. H. V., Ojha, S. K., Vijayakumar, M., & Verma, A. (2010). An analytical review of plants for anti-diabetic activity with their phytoconstituent and mechanism of action. International Journal of Pharmaceutical Sciences and Research, 1(1), 29–46.
   Google Scholar
• Biyani, M.K., Banavalikar, M.M., Suthar, A.C., Shahani, S., Sivakami, S. and Vidri, J. (2003). Antihyperglycemic effects of three extracts from Momordica charantia. Journal of Ethanopharmocology, 88(1), 107–111. https://doi.org/10.1016/S0378-8741(03)00184-3
   PubMed Web of Science ®Google Scholar
• Bortolotti, M., Mercatelli, D., & Polito, L. (2019). Momordica charantia, a nutraceutical approach for inflammatory related diseases. Frontiers in Pharmacology, 10, 486. https://doi.org/10.3389/fphar.2019.00486
   PubMed Web of Science ®Google Scholar
• Chen, Q., Chan, L. L., & Li, E. T. (2003). Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. The Journal of Nutrition, 133(4), 1088–1093. https://doi.org/10.1093/jn/133.4.1088
   PubMed Web of Science ®Google Scholar
• Chen, Y., Liu, Z. X., & Wu, C. S. (2010). Study on extracting technology of saponins from bitter melon. Guangzhou Chemical Industries, 38(1), 59–61.
   Google Scholar
• Çiçek, S. S. (2022). Momordica charantia L.— diabetes-related bioactivities, quality control, and safety considerations. Frontiers in Pharmacology, 1801. https://doi.org/10.3389/fphar.2022.904643
   Google Scholar
• Clouatre, D. L., Rao, S. N., & Preuss, H. G. (2011). Bitter melon extracts in diabetic and normal rats favorably influence blood glucose and blood pressure regulation. Journal of Medicinal Food, 14(12), 1496–1504. https://doi.org/10.1089/jmf.2010.0276
   PubMed Web of Science ®Google Scholar
• Cummings, D. E., & Overduin, J. (2007). Gastrointestinal regulation of food intake. Journal of Clinical Investigation, 117(1), 13–23. https://doi.org/10.1172/JCI30227
   PubMed Web of Science ®Google Scholar
• Dwijayanti, D. R., Okuyama, T., Okumura, T., Ikeya, Y., & Nishizawa, M. (2019). The anti-inflammatory effects of Indonesian and Japanese bitter melon (Momordica charantia L.) fruit extracts on interleukin-1β-treated hepatocytes. Functional Foods in Health and Disease, 9(1), 16–33. https://doi.org/10.31989/ffhd.v9i1.560
   Web of Science ®Google Scholar
• Dwijayanti, D. R., Shimada, T., Ishii, T., Okuyama, T., Ikeya, Y., Mukai, E., & Nishizawa, M. (2020). Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice. Phytotherapy Research, 34(6), 1338–1346. https://doi.org/10.1002/ptr.6600
   PubMed Web of Science ®Google Scholar
• Fang, E. F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V. A., Wong, J. H., & Ng, T. B. (2019). Emerging antitumor activities of the bitter melon (Momordica charantia). Current Protein & Peptide Science, 20(3), 296–301. https://doi.org/10.2174/1389203719666180622095800
   PubMed Web of Science ®Google Scholar
• Fernandes, N. P., Lagishetty, C. V., Panda, V. S., & Naik, S. R. (2007). An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complementary and Alternative Medicine, 7(1), 29. https://doi.org/10.1186/1472-6882-7-29
   PubMedGoogle Scholar
• Gadang, V., Gilbert, W., Hettiararchchy, N., Horax, R., Katwa, L., & Devareddy, L. (2011). Dietary bitter melon seed increases peroxisome proliferator-activated receptor-γ gene expression in adipose tissue, down-regulates the nuclear factor-κB expression, and alleviates the symptoms associated with metabolic syndrome. Journal of Medicinal Food, 14(1–2), 86–93. https://doi.org/10.1089/jmf.2010.0010
   PubMed Web of Science ®Google Scholar
• Gao, Y., Li, X., Huang, Y., Chen, J., & Qiu, M. (2021). Bitter melon and diabetes mellitus. Food Reviews International, 39(1), 1–21. https://doi.org/10.1080/87559129.2021.1923733
   Web of Science ®Google Scholar
• Gayathry, K. S., & John, J. A. (2022). A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Production, Processing and Nutrition, 4(1), 10. https://doi.org/10.1186/s43014-022-00089-x
   Google Scholar
• Gill, N. S., Rani, P., Arora, R., Dhawan, V., & Bali, M. (2012). Evaluation of antioxidant, antiinflammatory and antiulcer potential of Momordica charantia methanolic seed extract. Research Journal of Phytochemistry, 6(4), 1–9. https://doi.org/10.3923/rjphyto.2012.96.104
   Google Scholar
• Habicht, S. D., Kind, V., Rudloff, S., Borsch, C., Mueller, A. S., Pallauf, J., Yang, R.-Y., & Krawinkel, M. B. (2011). Quantification of antidiabetic extracts and compounds in bitter gourd varieties. Food Chemistry, 126(1), 172–176. https://doi.org/10.1016/j.foodchem.2010.10.094
   Web of Science ®Google Scholar
• Harborne, J. B. (2005). Phytochemical methods. A guide to modern techniques of plant analysis (3rd ed.). Springer Pvt. Ltd.
   Google Scholar
• Hazarika, R., Parida, P., Neog, B., & Yadav, R. N. S. (2012). Binding energy calculation of GSK-3 protein of human against some anti-diabetic compounds of Momordica charantia linn (bitter melon). Bioinformation, 8(6), 251. https://doi.org/10.6026/97320630008251
   PubMedGoogle Scholar
• Hossain, M. A., Mostofa, M., Debnath, D., Alam, A. K. M. R., Yasmin, Z., & Moitry, N. F. (2012). Antihyperglycemic and antihyperlipidemic of Karala (Momordica charantia) fruits in streptozotocin induced diabetic rats. Journal of Environmental Science & Natural Resources, 5(1), 29–37. https://doi.org/10.3329/jesnr.v5i1.11550
   Google Scholar
• Huang, H. L., Hong, Y. W., Wong, Y. H., Chen, Y. N., Chyuan, J. H., Huang, C. J., & Chao, P. M. (2008). Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. The British Journal of Nutrition, 99(2), 230–239. https://doi.org/10.1017/S0007114507793947
   PubMed Web of Science ®Google Scholar
• Hussain, M. S., Jahan, N., Rashid, M. M. O., Hossain, M. S., Chen, U., & Rahman, N. (2019). Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model. Heliyon, 5(5), e01739. https://doi.org/10.1016/j.heliyon.2019.e01739
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. (2021). International diabetes federation. IDF diabetes atlas (10thed.). www.diabetesatlas.org
   Google Scholar
• Jafri, S. A., Ismail, M. S., & Zaman, G. (2009). Effect of Momordica charantia (karela) in alloxan induced diabetic rats. Pakistan Journal of Science, 61(4), 220–222.
   Google Scholar
• Jeong, J., Lee, S., Hue, J., Lee, K., Nam, S. Y., & Yun, Y. W. (2008). Effect of bitter melon (Momordica Charantia) on antidiabetic activity in C57BL/6J db/db mice. Korean Journal of Veterinary Research, 48(3), 327–336.
   Google Scholar
• Karagöz, I. K., Karagöz, A., Özkalaycı, F., Doğan, C., Kocabay, G., & Elbay, A. (2021, August). Relation between platelet reactivity levels and diabetic retinopathy stage in patient with type 2 diabetes mellitus by using multiplate whole blood aggregometry. Seminars in Ophthalmology, 36(5–6), 392–399. Taylor & Francis. https://doi.org/10.1080/08820538.2021.1893759
   PubMed Web of Science ®Google Scholar
• Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000). Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology & Metabolism, 85(7), 2402–2410. https://doi.org/10.1210/jcem.85.7.6661
   PubMed Web of Science ®Google Scholar
• Ketut, D. M., Adnyana, D. P. A., Rinaldhi, C. P., Octaviani, R. R., & Cempaka, D. K. S. (2019). The antidiabetic effect of bitter melon (Momordica charantia L.) extracts towards glucose concentration, langerhans islets, and leydig cells of hyperglycemic mice (Rattus norvegicus). EurAsian Journal of BioSciences, 13(2), 757–762. https://web.p.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=13079867&AN=149914670&h=ndz0mEnVLAxvNd8ZNN7QRWlI6RNQcxDqWzuTPutqoiJUDOFj4BQ8jXv%2bVdzNLQ2K3Xa%2fvW%2bH5csIDYNW52sFtA%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d13079867%26AN%3d149914670
   Google Scholar
• Kim, J., Cho, H., Moon, S., Kim, K., & Ku, S. (2012). Synergic effects of bitter melon and β-glucan composition on STZ-Induced rat diabetes and its complications. Journal of Microbiology and Biotechnology, 22(1), 147–155. https://doi.org/10.4014/jmb.1106.06037
   PubMed Web of Science ®Google Scholar
• Kim, J. I., Paik, J. K., Kim, O. Y., Park, H. W., Lee, J. H., Jang, Y., & Lee, J. H. (2011). Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis, 215(1), 189–195. https://doi.org/10.1016/j.atherosclerosis.2010.11.036
   PubMed Web of Science ®Google Scholar
• Klomann, S. D., Mueller, A. S., Pallauf, J., & Krawinkel, M. B. (2010). Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice. The British Journal of Nutrition, 104(11), 1613–1620. https://doi.org/10.1017/S0007114510002680
   PubMed Web of Science ®Google Scholar
• Kole, C., Matsumura, H., & Behera, T. K. (Eds.). (2020). The bitter gourd genome. Springer. https://doi.org/10.1007/978-3-030-15062-4
   Google Scholar
• Krawinkel, M. B., & Keding, G. B. (2006). Bitter Gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutrition Reviews, 7(7), 331–337. https://doi.org/10.1111/j.1753-4887.2006.tb00217.x
   Google Scholar
• Li-Dong, T., Ming-Wei, Z., Si-Yuan, G., Rui-Fen, Z., Jian-Wei, C., Zhen-Cheng, W., Yan, Z., & Xiao-Jun, T. (2008). Comparison of saponin contents of different varieties of Momordica charantia L. and their inhibition on α-glucosidase activity. Scientia Agricultura sinica, 41(10), 3415–3421.
   Google Scholar
• Liu, Z., Gong, J., Huang, W., Lu, F., Dong, H., & Ullah, R. (2021). The effect of Momordica charantia in the treatment of diabetes mellitus: A review. Evid Based Complement Altern Med, 2021, 1–14. https://doi.org/10.1155/2021/3796265
   Web of Science ®Google Scholar
• Li, Z., Xia, A., Li, S., Yang, G., Jin, W., Zhang, M., & Wang, S. (2020). The pharmacological properties and therapeutic use of bitter melon (Momordica charantia L.). Current Pharmacology Reports, 6(3), 103–109. https://doi.org/10.1007/s40495-020-00219-4
   Google Scholar
• Lucas, E. A., Dumancas, G. G., Smith, B. J., Clarke, S. L., & Arjmandi, B. H. (2010). In bioactive foods in promoting health ( V. R. Preedy, Ed.). Academic Press. https://doi.org/10.1016/B978-0-12-374628-3.00035-9
   Google Scholar
• Mahmood, A., Raja, G. K., Mahmood, T., Gulfraz, M., & Khanum, A. (2012). Isolation and characterization of antimicrobial activity conferring component (s) from seeds of bitter gourd (Momordica charantia). Journal of Medicinal Plants Research, 6(4), 566–573. https://doi.org/10.5897/JMPR10.613
   Google Scholar
• Majumda, B., & Debnath, T. (2014). Immunomodulatory activity of ethanolic extract of bitter gourd (Momordica charantia) in experimental models. Journal of Biomedical and Pharmaceutical Research, 3(3), 59–63.
   Google Scholar
• Matsui, S., Yamane, T., Takita, T., Oishi, Y., & Kobayashi-Hattori, K. (2013). The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver. Nutrition Research, 33(7), 580–585. https://doi.org/10.1016/j.nutres.2013.05.002
   PubMed Web of Science ®Google Scholar
• Mohammady, I., Elattar, S., Mohammed, S., & Ewais, M. (2012). An evaluation of anti-diabetic and anti-lipidemic properties of Momordica charantia (bitter melon) fruit extract in experimentally induced diabetes. Life Science Journal, 9(2), 363–374.
   Google Scholar
• Obadoni, B. O., & Ochuko, P. O. (2001). Phytochemical studies and comparative efficacy of the crude extract of some homeostatic plants in Edo and Delta states of Nigeria. Global Journal of Pure and Applied Sciences, 8(2), 203–208. https://doi.org/10.4314/gjpas.v8i2.16033
   Google Scholar
• Oishi, Y., Sakamoto, T., Udagawa, H., Taniguchi, H., Kobayashi-Hattori, K., Ozawa, Y., & Takita, T. (2007). Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Bioscience, Biotechnology, and Biochemistry, 71(3), 735–740. https://doi.org/10.1271/bbb.60570
   PubMed Web of Science ®Google Scholar
• Panda, B. C., Mondal, S., Devi, K. S. P., Maiti, T. K., Khatua, S., Acharya, K., & Islam, S. S. (2015). Pectic polysaccharide from the green fruits of Momordica charantia (Karela): Structural characterization and study of immunoenhancing and antioxidant properties. Carbohydrate Research, 401, 24–31. https://doi.org/10.1016/j.carres.2014.10.015
   PubMed Web of Science ®Google Scholar
• Poovitha, S., & Parani, M. (2016). In vitro and in vivo α-amylase and αglucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complementary and Alternative Medicine, 16(Suppl 1), 185. https://doi.org/10.1186/s12906-016-1085-1
   PubMed Web of Science ®Google Scholar
• Reyes, B. A. S., Bautista, N. D., Tanquilut, N. C., Anunciado, R. V., Leung, A. B., Sanchez, G. C., Magtoto, R. L., Castronuevo, P., Tsukamura, H., & Maeda, K. I. (2006). Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. Journal of Ethnopharmacology, 105(1–2), 196–200. https://doi.org/10.1016/j.jep.2005.10.018
   PubMed Web of Science ®Google Scholar
• Rohajatien, U., Sriwahyuni, T., Estiasih, E., & Sriwahyuni, E. (2018). Bitter melon (Momordica charantia L) fruit decreased blood glucose level and improved lipid profile of streptozotocin induced hyperglycemia rats. Current Research in Nutrition and Food Science Journal, 6(2), 359–370. https://doi.org/10.12944/CRNFSJ.6.2.11
   Web of Science ®Google Scholar
• Sa’adah, N. N., & Nurhayati, A. P. D. (2020). Antihiperlipidemic activity of the methanolic extract of parijoto (medinilla speciosa) on the protein profile of hyperlipidemic rats.
   Google Scholar
• Saad, D. Y., Soliman, M. M., Baiomy, A. A., Yassin, M. H., & El-Sawy, H. B. (2017). Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: Biochemical, molecular and histopathological study. BMC Complementary and Alternative Medicine, 17(1), 319. https://doi.org/10.1186/s12906-017-1833-x
   PubMedGoogle Scholar
• Saeed, F., Afzaal, M., Niaz, B., Arshad, M. U., Tufail, T., Hussain, M. B., & Javed, A. (2018). Bitter melon (Momordica charantia): A natural healthy vegetable. International Journal of Food Properties, 21(1), 1270–1290. https://doi.org/10.1080/10942912.2018.1446023
   Web of Science ®Google Scholar
• Sathishsekar, D., & Subramanian, S. (2005). Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia Pacific Journal of Clinical Nutrition, 14(2), 153–158.
   PubMed Web of Science ®Google Scholar
• Sato, M., Ueda, T., Nagata, K., Shiratake, S., Tomoyori, H., Kawakami, M., Ozaki, Y., Okubo, H., Shirouchi, B., & Imaizumi, K. (2011). Dietary kakrol (Momordica dioica Roxb.) flesh inhibits triacylglycerol absorption and lowers the risk for development of fatty liver in rats. Experimental Biology and Medicine, 236(10), 1139–1146. https://doi.org/10.1258/ebm.2011.011037
   Web of Science ®Google Scholar
• Senanayake, G. V., Maruyama, M., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., & Ohta, H. (2004). The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets. Journal of Nutritional Science and Vitaminology, 50(4), 253–257. https://doi.org/10.3177/jnsv.50.253
   PubMed Web of Science ®Google Scholar
• Shetty, A. K., Kumar, G. S., Sambaiah, K., & Salimath, P. V. (2005). Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods for Human Nutrition, 60(3), 109–112. https://doi.org/10.1007/s11130-005-6837-x
   PubMed Web of Science ®Google Scholar
• Singh, N., & Gupta, M. (2007). Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian Journal of Experimental Biology, 45(12), 1055–1062.
   PubMed Web of Science ®Google Scholar
• Smail, M., Howarth, F., Abdulkhalek, S., Ismail, A. M., Singh, R. B., Hanoman, C. & Singh, J. (2020). Medicinal and anti-oxidant effects of Bitter Melon (Momordica charantia) in the treatment of diabetic cardiomyopathy. World Heart Journal, 12(3), 1–9. https://clok.uclan.ac.uk/35904/1/35904%20Proof%20for%20bitter%20melon2020.pdf
   Google Scholar
• Steel, R. G. D., & Torrie, J. H. (1986). Principles and procedures of statistics: A biometrical approach. McGraw-Hill.
   Google Scholar
• Sultan, F., Saeed, M. T., Ahmed, A., Riaz, S., Amarowicz, N., Bigiu, R., Manea, R., & Manea, R. (2021). Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment. Plants, 10(4), 730. https://doi.org/10.3390/plants10040730
   Google Scholar
• Sundaram, E. N., & Kumar, S. (2002). Bitter melon holds hope for treating diabetes. Homeopathic Society, 22, 4.
   Google Scholar
• Temitope, A. G., Sheriff, O. L., Azeezat, Y. F., Taofik, A., & Fatimah, A. I. (2013). Cardioprotective properties of Momordica charantia in Albino Rats. African Journal of Scientific Research, 11(1), 600–610.
   Google Scholar
• Tymoczko, J. L., Stryer, B. T., Stryer, L., & Berg, J. M. (2002). Biochemistry ( W. H. Freeman, Ed.). W.H. Freeman.
   Google Scholar
• Uebanso, T., Arai, H., Taketani, Y., Fukaya, M., Yamamoto, H., Mizuno, A., Uryu, K., Hada, T., & Takeda, E. (2007). Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. Journal of Nutritional Science and Vitaminology (Tokyo), 53(6), 482–486. https://doi.org/10.3177/jnsv.53.482
   PubMed Web of Science ®Google Scholar
• Wang, Q., Deng, Y., Zhang, M., Zhang, R., Zhang, Y., Tang, X., Wei, Z., & Chi, J. (2011). Continuous extraction of saponin and polysaccharide from Momordica charantia L. and their inhibitory effect on α-glucosidase. Scientia Agricultura sinica, 44(19), 4058–4065.
   Google Scholar
• Wang, S., Li, Z., Yang, G., Ho, C. T., & Li, S. (2017). Momordica charantia: A popular health-promoting vegetable with multifunctionality. Food & Function, 8(5), 1749–1762. https://doi.org/10.1039/C6FO01812B
   PubMed Web of Science ®Google Scholar
• WHO. (2021). Cardiovascular diseases (CVDs). Retrieved September 15, 2022, from http://www.int/news-room/factsheets/detail/cardiovascular-diseases(cvds)
   Google Scholar
• Xiang, L., Huang, X., Chen, L., Rao, P., & Ke, L. (2007). The reparative effects of Momordica charantia Linn. extract on HIT-T15 pancreatic beta cells. Asia Pacific journal of clinical nutrition, 16(1), 249–252. https://doi.org/10.5281/zenodo.1086261
   PubMedGoogle Scholar
• Youn, K. S., Park, E. H., & Yoon, K. Y. (2019). Quality characteristics and antioxidant activity of bitter melon (Momordica charantia L.) dried by different methods. Korean Journal of Food Preservation, 26(2), 185–193. https://doi.org/10.11002/kjfp.2019.26.2.185
   Google Scholar
• Yuan, X. Q., Yuan, C., & Liu, H. M. (2012). Hypoglycemic effect of Momordica charantia L. Var. abbreviata ser. protein hydrolysate prepared with alcalase. Applied Mechanics & Materials, 195-196, 324–329. https://doi.org/10.4028/www.scientific.net/AMM.195-196.324
   Google Scholar
• Zawada, A., Machowiak, A., Rychter, A. M., Ratajczak, A. E., Szymczak-Tomczak, A., Dobrowolska, A., & Krela-Ka ´zmierczak, I. (2022). Accumulation of advanced glycation end-products in the body and dietary habits. Nutrients, 14(19), 3982. https://doi.org/10.3390/nu14193982
   PubMed Web of Science ®Google Scholar
• Zhang, F., Zhang, X., Yu, J., Tan, Y., Guo, P., & Wu, C. (2020). The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) in high-fat diet (HFD)-Induced hyperlipidemic mice. Biomedicine & Pharmacotherapy, 131, 110667. https://doi.org/10.1016/j.biopha.2020.110667
   PubMed Web of Science ®Google Scholar